Amanote Research
Register
Sign In
Sphingolipid Metabolism in the Pathophysiology and Treatment of Alzheimer’s Disease
doi 10.26481/dis.20191114sc
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
University of Maastricht
Related search
Pathophysiology and Management of Alzheimer’s Disease: An Overview
Journal of Analytical & Pharmaceutical Research
Sphingolipid-Enriched Extracellular Vesicles and Alzheimer’s Disease: A Decade of Research
Journal of Alzheimer's Disease
Gerontology
Clinical Psychology
Mental Health
Psychiatry
Geriatrics
Medicine
Neuroscience
The Pathophysiology and Pharmacological Treatment of Huntington Disease
Behavioural Neurology
Medicine
Neurology
Physiological Psychology
Neuropsychology
Renal Disease Pathophysiology and Treatment: Contributions From the Rat
DMM Disease Models and Mechanisms
Immunology
Molecular Biology
Biochemistry
Microbiology
Neuroscience
Medicine
Genetics
Network-Based Analysis of the Sphingolipid Metabolism in Hypertension
Frontiers in Genetics
Genetics
Molecular Medicine
Molecular Approaches to the Treatment, Prophylaxis, and Diagnosis of Alzheimer’s Disease: Tangle Formation, Amyloid-Β, and Microglia in Alzheimer’s Disease
Journal of Pharmacological Sciences
Molecular Medicine
Pharmacology
Alterations in Cholesterol Metabolism-Related Genes in Sporadic Alzheimer’s Disease
Neurobiology of Aging
Aging
Gerontology
Developmental Biology
Geriatrics
Neuroscience
Neurology
Links Between Insulin Resistance, Lipoprotein Metabolism and Amyloidosis in Alzheimer’s Disease
Health
Current Understanding of Alzheimer’s Disease Diagnosis and Treatment
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
